Corporate Support ISAL XX 2027

The organizers of ACUTE LEUKEMIAS XX (ISALXX) wish to thank all corporate partners to actively for their support of the international symposium ACUTE LEUKEMIAS XX, Munich, March 14-17, 2027.

The organizers highly value the partnerships and their important role that members of this community play by supporting the international symposium ACUTE LEUKEMIAS in their effort to provide hematologists with high quality educational sessions thus rendering all attendees the opportunity to discuss the most recent findings in basic research and results of clinical studies on the field of acute leukemias.

Corporate Support ISAL XX 2027

Abbvie Deutschland GmbH
Amgen GmbH
Astellas Pharma GmbH
Daiichi Sankyo GmbH
Jazz Pharmaceuticals
Neovii Biotech GmbN
Otsuka Pharma GmbH
Servier Deutschland GmbH
Servier France